Director, Vendor Management

The Director, Vendor Management is responsible for the management and oversight of assigned Suppliers/Categories (CRO's, ARO's and Phase I Units). This role involves strategic planning and execution of vendor governance meetings, serving as the primary contact and escalation point at the relationship level, and monitoring and managing vendor performance. Additionally, the Director will work closely with Expertise Areas to implement vendor process improvement initiatives. The role will involve collaborating with senior management to drive organizational success.

Reports to the Senior Director or VP, Vendor Management.

Key Responsibilities:

• Strategic Vendor Management: Overall relationship and portfolio performance for the suppliers/categories listed above.
• Governance Meetings: Plan and execute vendor governance meetings to ensure alignment and performance.
• Primary Contact & Escalation Point: Act as the main point of contact for vendors and manage escalations at the relationship level.
• Performance Management: In partnership with EA's, set performance targets, monitor progress, and implement corrective actions as necessary. Ensure contractual and organizational expectations are met.
• Process Improvement: In collaboration with Suppliers and EAs identify and implement vendor process improvement initiatives.
• Financial Oversight: Manage portfolio of business exceeding $500M in value, supporting all clinical trials in the Development portfolio.
• Stakeholder Engagement: Collaborate with internal and external stakeholders to drive initiatives and build strong partnerships.
• Reporting & Analysis: Provide regular performance reports and analyses to senior management.
• Strategic Leadership: Lead/participate in Trial Delivery Optimization initiatives, intended to drive efficiency, quality and progression of our explosive pipeline.

• Team Management: Lead, mentor, and develop a high-performing team, fostering a culture of continuous improvement and innovation.
• Risk Management: Identify potential risks and develop mitigation strategies to safeguard departmental and organizational objectives.
• Reporting & Analysis: Provide regular reports and analyses to senior management, highlighting key metrics and insights.

Qualifications:

• Bachelor's degree in a related field; Master's degree preferred.
• Minimum of 10 years of experience in senior management or vendor management within the global clinical research or pharmaceutical industry.
• Proven track record of managing high-value contracts and vendor relationships.
• Strong leadership, team management and strategic planning skills.
• Excellent communication and interpersonal abilities.
• Proficient in relevant software/tools for vendor management and reporting.

Competencies:

• Strategic Thinking: Ability to develop and implement long-term innovative strategies for vendor management.

• Leadership: Strong ability to lead, mentor, and develop a high-performing team. Strong project management skills and effective matrix leader. Able to hold vendors accountable to deliverables.
• Financial Acumen: Expertise in managing large-scale contracts and financial planning.
• Decision Making: Exceptional problem-solving skills and sound judgment.
• Collaboration: Proven ability to work collaboratively with diverse stakeholders.
• Adaptability: Flexible and able to manage change effectively.
• Knowledge: Experience in pharmaceutical/biotechnology and extensive knowledge of drug development processes, ICH-GCP guidelines, 21 CRF Part 11, and major Health Authority regulations as they pertain to the operational aspects of clinical trials

• Ability to travel up to 30%
• Clear alignment with Alnylam Core Values
  • Commitment to People
  • Fiercely Innovative
  • Purposeful Urgency
  • Open Culture
  • Passion for Excellence

About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.